Prot #PUMA-NER-5201: An Open-Label, Phase 2 Basket Study Of Neratinib In Patients With Solid Tumors With Somatic Activating HER Mutations

Project: Research project

Status	Active
Effective start/end date	5/9/18 → 5/9/24

Project Details